Nordic Pharma has launched Nordimet - the first button-free, once-weekly PEN device containing the active substance methotrexate - across the UK, offering patients with various auto-immune conditions ...

Findings from a clinical trial has recommended methotrexate for children with severe atopic dermatitis. The study led by King's College London, compared the safety and efficacy of ciclosporin with ...

Methotrexate is a strong medicine. The FDA approved it to treat adults with severe, disabling psoriasis that cannot be controlled with medicine applied to the skin or light treatments. Methotrexate ...

A two-week break from taking methotrexate after a Covid-19 booster vaccine can help improve its effectiveness, a UK trial has suggested. Analysis of immune responses in 127 participants who were ...

June 30 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by ...

Future Market Insights offers a comprehensive analysis of the methotrexate drug market. Gain access to our in-depth report, which explores demand and supply trends, technology roadmap, market ...

This trial looked at mercaptopurine and methotrexate for people with breast or ovarian cancer who had an inherited fault in the BRCA1 or BRCA2 gene. The trial was supported by Cancer Research UK. It ...

COPENHAGEN, Denmark, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The first evidence of high dose methotrexate related toxicity (HDMTX) in Spain was presented today at Virtual ISPOR Europe 2021, a global ...